Differentiated thyroid cancer: millions spent with no tangible gain?

Area of Science:

• Endocrinology
• Surgical Oncology
• Health Economics

Background:

• Global incidence of differentiated thyroid cancer (DTC) has significantly increased.
• The impact of rising DTC diagnoses on thyroidectomy rates and healthcare costs remains unclear.

Purpose of the Study:

• To investigate trends in DTC and thyroidectomy incidence in New South Wales (NSW), Australia.
• To assess the economic burden associated with increased thyroidectomy procedures.
• To evaluate the relationship between DTC incidence, surgical rates, and mortality.

Main Methods:

• Poisson regression modeling was used to analyze annual DTC and thyroidectomy incidence by sex in NSW from 2003-2012.
• Incidence rates from 2002 were used as a baseline to calculate cumulative increases over the subsequent decade.
• Economic burden was estimated by multiplying excess thyroidectomies by the national average cost of uncomplicated thyroidectomy.

Main Results:

• Both DTC and thyroidectomy incidence doubled in NSW between 2003 and 2012.
• DTC-specific mortality rates remained unchanged during the study period.
• An estimated 2196 additional thyroidectomies occurred, resulting in an excess cost of over AUD$18.6 million over the decade.

Conclusions:

• The doubling of DTC and thyroidectomy rates without a change in mortality suggests potential overdetection.
• The rising healthcare expenditure associated with these procedures may be avoidable if linked to overdiagnosis.
• A conservative approach to DTC management and reducing unnecessary detection are recommended to lower costs and patient harm.